Your browser doesn't support javascript.
loading
Understanding the Regulatory Pathways Used to Develop, Evaluate, Authorize, and Approve New Drugs and Vaccines in the United States.
Domachowske, Joseph B.
Afiliação
  • Domachowske JB; Department of Pediatrics, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, USA.
J Pediatric Infect Dis Soc ; 13(Supplement_2): S93-S102, 2024 Jul 12.
Article em En | MEDLINE | ID: mdl-38995086
ABSTRACT
The United States (U.S.) Food and Drug Administration (FDA) oversees the safety and quality of drugs and vaccines that are used in the U.S. Administration of the FDA falls under the jurisdiction of the U.S. Department of Health and Human Services (HHS). The regulatory oversight of the FDA is complex and comprehensive, requiring the various roles and responsibilities to be divided across six main centers. The activities of two of these centers, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) are the primary focus of this review.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Vacinas / Aprovação de Drogas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Vacinas / Aprovação de Drogas Idioma: En Ano de publicação: 2024 Tipo de documento: Article